Tabula Rasa HealthCare (TRHC) Stock Forecast, Price & News

4 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Tabula Rasa HealthCare in the last twelve months. There are currently 2 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" TRHC shares.
View TRHC analyst ratings or view top-rated stocks.

4 brokers have issued twelve-month price targets for Tabula Rasa HealthCare's shares. Their TRHC share price forecasts range from $5.00 to $10.00. On average, they anticipate the company's share price to reach $6.63 in the next year. This suggests a possible upside of 5.2% from the stock's current price.
View analysts price targets for TRHC or view top-rated stocks among Wall Street analysts.

Tabula Rasa HealthCare's stock was trading at $4.95 at the beginning of 2023. Since then, TRHC stock has increased by 27.3% and is now trading at $6.30.
View the best growth stocks for 2023 here.

Tabula Rasa HealthCare saw a drop in short interest in May. As of May 15th, there was short interest totaling 1,380,000 shares, a drop of 13.8% from the April 30th total of 1,600,000 shares. Based on an average trading volume of 116,800 shares, the days-to-cover ratio is presently 11.8 days. Currently, 5.8% of the shares of the stock are sold short.
View Tabula Rasa HealthCare's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 3rd 2023.
View our TRHC earnings forecast.

Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) issued its quarterly earnings results on Monday, May, 8th. The company reported ($0.12) earnings per share for the quarter, beating the consensus estimate of ($0.31) by $0.19. The company earned $88.28 million during the quarter, compared to analysts' expectations of $83.86 million. Tabula Rasa HealthCare had a negative trailing twelve-month return on equity of 472.90% and a negative net margin of 42.17%.

Tabula Rasa HealthCare issued an update on its second quarter 2023 earnings guidance on Monday, May, 8th. The company provided EPS guidance of for the period. The company issued revenue guidance of $88.00 million-$90.00 million, compared to the consensus revenue estimate of $85.94 million.

24 employees have rated Tabula Rasa HealthCare Chief Executive Officer Calvin H. Knowlton, BScPharm, MDiv, PhD on Glassdoor.com. Calvin H. Knowlton, BScPharm, MDiv, PhD has an approval rating of 91% among the company's employees. This puts Calvin H. Knowlton, BScPharm, MDiv, PhD in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Tabula Rasa HealthCare investors own include NVIDIA (NVDA), Advanced Micro Devices (AMD), QUALCOMM (QCOM), Adobe (ADBE), Micron Technology (MU), Boeing (BA), Salesforce (CRM), Intel (INTC) and Netflix (NFLX).

(TRHC) raised $60 million in an initial public offering (IPO) on Thursday, September 29th 2016. The company issued 4,300,000 shares at $13.00-$15.00 per share. Wells Fargo Securities, UBS Investment Bank and Piper Jaffray acted as the underwriters for the IPO and Baird and Stifel were co-managers.

Tabula Rasa HealthCare trades on the NASDAQ under the ticker symbol "TRHC."

Tabula Rasa HealthCare's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include UBS Group AG (4.84%), Wasatch Advisors LP (3.27%), JPMorgan Chase & Co. (1.18%), Acadian Asset Management LLC (1.15%), Geode Capital Management LLC (0.92%) and Spears Abacus Advisors LLC (0.88%). Insiders that own company stock include Andrea Carolan Speers, Brian W Adams, Calvin H Knowlton, Dennis Helling, Gordon Tunstall, Indaba Capital Management, LP, Jan Berger, Michael Greenhalgh, Michael J Purcell, Orsula V Knowlton, Orsula V Knowlton, Samira Beckwith and Thomas Cancro.
View institutional ownership trends.

Shares of TRHC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of TRHC stock can currently be purchased for approximately $6.30.

Tabula Rasa HealthCare (NASDAQ:TRHC) has a market capitalization of $169.16 million and generates $320.68 million in revenue each year. The company earns $-147,510,000.00 in net income (profit) each year or ($5.54) on an earnings per share basis.

The company employs 1,027 workers across the globe.

Tabula Rasa HealthCare's mailing address is 228 STRAWBRIDGE DRIVE SUITE 100, MOORESTOWN NJ, 08057. The official website for the company is www.tabularasahealthcare.com. The company can be reached via phone at (866) 648-2767 or via email at tabularasa@westwicke.com.